GSL SELECTED FOR INNOVATE UK SCALEUP PROGRAMME
Posted on: 11/05/2026
The Innovate UK Business Growth Scaleup Programme supports a select group of companies on a journey to exponential growth. Guilford Street Laboratories (GSL) is proud to have been accepted, following a rigorous three-stage screening process. The initiative will help GSL scale up its world leading digital services and technology innovations.
The programme is designed to support highly innovative, ambitious, high-growth oriented companies already on their scaling journey, whose innovations or business models can disrupt an existing market, and who are establishing or already implementing their international markets strategy. The priorities for participants can for example include one or more of: finance and funding strategy, structuring for scale, internationalisation through to laying the groundwork for an IPO.
At the centre of the service is a team of high calibre scaleup directors who operate together as a board and provide each of the companies on the programme with a matrix of skills and connectivity. The scaleup directors will help GSL work with the company to understand the particular set of needs that it faces on its scaling journey and help it take decisive steps towards game changing investment and expansion on the international stage.
Martin McGurk Deputy Director Business Growth - Innovate UK , says, ‘Our work with the GSL team is a great example of just how much value this programme can add to the endeavours of the business leaders we support. The inputs are varied and blend strategic thinking with invaluable hands-on tactical guidance, to create outcomes that deliver real commercial advantage. It’s a pleasure working with the GSL Directors at this pivotal time for their business.’
Speaking about the programme, he adds, ‘Admission onto the Scaleup Programme is a rigorous and highly selective process. To be eligible, selectors look for innovative, ambitious, high-growth oriented companies that are already on their scaling journey. GSL is a perfect candidate in this respect and we are looking forward to helping it scale up, drive growth, and realise its potential as a high-performing and world leading business’.
About GSL
GSL is using machine learning-driven omic technology to deliver new innovative assays with higher precision. GSL aims to revolutionise diagnosis and monitoring of treatment for clinical trials and equip clients with crucial data that is more accurate, sensitive and specific than currently available. This includes diagnoses for rare paediatric conditions as well as adult diseases such as Parkinson’s, Alzheimer’s and hypertrophic cardiomyopathy.
About Innovate UK Business Growth
Innovate UK Business Growth is Innovate UK’s national business growth and scaling service. We empower ambitious innovation-focused SMEs in every sector and from seed to scaling stage, to succeed and become highly investable.
Our specialists are embedded in all nations and regions and help leadership teams from client businesses hone the commercial strategy around their innovations. This extends to support, in the form of advice, access to resources and introductions to partners, across priority areas such as effective innovation management, internationalisation and investment readiness.
The most dynamic scaling businesses may be eligible for the Innovate UK Business Growth Scaleup Programme. This offers enhanced support via an expert Scaleup Board and its extended connections, that prepares clients for serious fundraising and international expansion.
